Top Institutions in Ophthalmology - Glaucoma and Epigenetics
Institutions leading in this area combine expertise in ophthalmology, glaucoma clinical research, and epigenetics, utilizing advanced molecular biology techniques such as DNA methylation profiling and epigenetic clock analysis alongside longitudinal clinical glaucoma assessments.
-
#1
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is a world leader in glaucoma research with pioneering studies linking epigenetic age acceleration to glaucoma progression, led by prominent researchers such as Dr. Felipe A. Medeiros. Their integration of clinical ophthalmology with molecular epigenetic techniques sets them apart.
Key Differentiators
- Ophthalmology
- Glaucoma Research
- Epigenetics
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is renowned for its comprehensive glaucoma clinical trials and molecular research, including epigenetic studies related to ocular diseases, supported by Harvard's strong biomedical research infrastructure.
Key Differentiators
- Ophthalmology
- Glaucoma
- Molecular Biology
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in glaucoma genetics and epigenetics, with a history of innovative research on molecular markers predicting disease progression and personalized medicine approaches in ophthalmology.
Key Differentiators
- Ophthalmology
- Glaucoma
- Genetics and Epigenetics
-
#4
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields and UCL combine clinical excellence in glaucoma care with cutting-edge research in epigenetics and biomarker discovery, contributing significantly to understanding molecular aging in eye diseases.
Key Differentiators
- Ophthalmology
- Glaucoma
- Epigenetics
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







